Get started
Author

Caili Tong

Remission of Disseminated Cancer After Systemic Oncolytic Virotherapy
2014 · Stephen J. Russell, Mark J. Federspiel, et al. · Mayo Clinic Proceedings · 275
Conditional Knockout Mice Reveal Distinct Functions for the Global Transcriptional Coactivators CBP and p300 in T-Cell Development
2006 · Lawryn H. Kasper, Tomofusa Fukuyama, et al. · Molecular and Cellular Biology · 214
Loss of CBP causes T cell lymphomagenesis in synergy with p27Kip1 insufficiency
2004 · Ningling Kang-Decker, Caili Tong, et al. · Cancer Cell · 109
PDF
Tumor and Vascular Targeting of a Novel Oncolytic Measles Virus Retargeted against the Urokinase Receptor
2009 · Yuqi Jing, Caili Tong, et al. · Cancer Research · 68
PDF
Association Between High Initial Tissue Levels of Cyclin D1 and Recurrence of Nasopharyngeal Carcinoma
2002 · Jin‐Ping Lai, Cai‐Li Tong, et al. · The Laryngoscope · 25
Immunoglobulin Variable Light Chain Restriction, Cytokine Expression and Plasma Cell-Stromal Cell Interactions in POEMS Syndrome Patients
2008 · Bharathi Aravamudan, Caili Tong, et al. · Blood · 19
HIV-1 Rev–binding protein accelerates cellular uptake of iron to drive Notch-induced T cell leukemogenesis in mice
2010 · Shariq S. Khwaja, Hudan Liu, et al. · Journal of Clinical Investigation · 16
PDF
Protease Activity of Urokinase and Tumor Progression in a Syngeneic Mammary Cancer Model
2006 · Jaime R. Merchan, Jian Tang, et al. · JNCI Journal of the National Cancer Institute · 12
Low Levels of Interleukin-1 Receptor Antagonist (IL-1RA) Predict Engraftment Syndrome after Autologous Stem Cell Transplantation in POEMS Syndrome and Other Plasma Cell Neoplasms
2013 · Alla Keyzner, Anita D'Souza, et al. · Transplantation and Cellular Therapy · 9
PDF
Targeting RAS-ERK pathway alterations with MEK inhibitors to improve chemosensitivity in high grade serous ovarian cancers
2023 · Nancy T. Nguyen, Alan Raetz, et al. · Gynecologic Oncology · 7
Geminin is required for Hox gene regulation to pattern the developing limb
2020 · Emily M.A. Lewis, Savita Sankar, et al. · Developmental Biology · 5
PDF
Ovarian Serous Carcinoma With a Novel HSP90AB1 Mutation in a Patient With Synchronous Primary Fallopian Tube Serous Carcinoma
2021 · JINPING LAI, CAILI TONG, et al. · Anticancer Research · 3
Unbiased assessment of APR-246 responsive p53 mutants in ovarian cancer
2026 · Anais Saunders, Caili Tong, et al. · Cell Death Discovery · 1
PDF
565 Blood biomarkers for predicting clinical response and delineating resistance mechanisms to tarlatamab in patients with metastatic small cell lung cancer
2025 · Linjun Zha, Tianhong Li, et al. · Regular and Young Investigator Award Abstracts · 1
PDF
Synchronous Basal Cell Carcinoma and Squamous Cell Carcinoma of Nasal Vestibule With Novel Unique Variants Identified by Whole-exome Sequencing
2021 · IDA GHLICHLOO, ZHONGBO JIN, et al. · In Vivo · 1
PDF
Geminin deficiency enhances survival in a murine medulloblastoma model by inducing apoptosis of preneoplastic granule neuron precursors
2017 · Savita Sankar, Ethan Patterson, et al. · Genes & Cancer · 1
PDF
Analysis of the Immunoglobulin Heavy and Light Chain Gene Expression and Mutations in POEMS Patients.
2009 · Bharathi Aravamudan, Caili Tong, et al. · Blood · 1
PP01.51: Impact of Germline Mutations and HLA Haplotypes on Clinical Response and Immune-Related Adverse Events (irAEs) in Lung Cancer Patients Treated with Immune Checkpoint Inhibitors
2026 · Birhan Alemnew, Dingning Liu, et al. · Journal of Thoracic Oncology
Abstract A046: Functional genetic screen of TP53 mutants reveals APR-246 sensitivity is mediated by p53 independent effects
2025 · Anais Saunders, Caili Tong, et al. · Cancer Research
The Role of TP53 Mutations in the Malignant Progression of Mucinous Borderline Ovarian Tumors: A Case Report and Literature Review
2025 · Meirong Liang, Sijun Xie, et al. · International Journal of Women s Health
PDF
Abstract 631: Functional genetics of APR-246 rescuable TP53 mutants
2024 · Anais Saunders, Caili Tong, et al. · Cancer Research
Data from Tumor and Vascular Targeting of a Novel Oncolytic Measles Virus Retargeted against the Urokinase Receptor
2023 · Yuqi Jing, Caili Tong, et al.
Supplementary Figure 1 from Tumor and Vascular Targeting of a Novel Oncolytic Measles Virus Retargeted against the Urokinase Receptor
2023 · Yuqi Jing, Caili Tong, et al.
Supplementary Figure 2 from Tumor and Vascular Targeting of a Novel Oncolytic Measles Virus Retargeted against the Urokinase Receptor
2023 · Yuqi Jing, Caili Tong, et al.
Data from Tumor and Vascular Targeting of a Novel Oncolytic Measles Virus Retargeted against the Urokinase Receptor
2023 · Yuqi Jing, Caili Tong, et al.
Works count: 33
Citation count: 767
H-index: 9
I10-index: 8
Year
Topic
Type